1 Min Read
Jan 12 (Reuters) -
* OncoImmune Inc - today announced that is has closed on a $15.0 million series a round of fundraising led by 3E Bioventures Capital Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.